University of South Florida and Tampa General Hospital Cancer Institute launch the “Microbial Oncogenesis and Cancer Therapy” ...

Estrella Immunopharma, Inc. ("Estrella" or the "Company"), a clinical stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS® T-cell therapies to treat cancer and autoimmune ...

A Phase 3 study assessed the second-line use of sintilimab combined with ICE vs placebo combined with ICE in managing patients with classical Hodgkin Lymphoma.